Vascular Surgeons See AI Handling Pre-Op Planning Within Two Years

**TL;DR**: AI tools could handle vascular surgery pre-operative planning within two years, though fully autonomous robotic procedures remain a decade away due to regulatory and technical barriers.

The pace of AI investment is staggering. Amazon, Google, Microsoft, and Meta have collectively earmarked over $600 billion for AI infrastructure in 2026 alone, signalling massive resources flowing toward healthcare applications.

Professor Mark Whiteley, a vascular surgeon at the Whiteley Clinic in London, predicts complete AI solutions for preoperative planning in aortic surgery will be available within two years. These systems will analyse CT scans, angiograms, and patient data to generate surgical plans, reducing planning time from hours to minutes.

The transition to fully integrated AI-enabled robotic surgery, however, faces steeper obstacles. Technical challenges around real-time decision-making in complex procedures combined with stringent regulatory requirements mean a five-to-ten-year timeline is more realistic. Current robotic systems like the Da Vinci require human surgeons to control every movement.

The broader AI landscape adds context. Some researchers at leading labs believe true artificial general intelligence could emerge within 12-24 months, though others dispute this timeline. The distinction matters: narrow AI excels at specific tasks like image analysis, while general intelligence would match human cognition across all domains.

The investment thesis faces recent pressure. The software ETF IGV has dropped 30% with price-to-earnings and price-to-sales ratios at multi-year lows. Major private equity firms including KKR, Blue Owl, and Blackstone have experienced 20-60% sell-offs, with Blue Owl freezing redemptions in some funds.

For patients, AI-assisted planning could mean faster diagnoses and more consistent surgical approaches. For surgeons, the technology likely serves as a tool rather than replacement, handling routine analysis while clinicians focus on complex decision-making and patient interaction. The next two years will test whether these predictions hold.